Thailand 3D Imaging Market Analysis Report 2022 to 2030

Thailand 3D Imaging Market Analysis

$ 3999

Thailand's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by the rise in Thailand’s health expenditure, the government expanding the healthcare infrastructure and services, and the rising incidence of chronic illnesses. The market is segmented by product, by application, end-user & by portability. Some of the major players include Siemens Healthineers, GE Healthcare & Meditop Co., Ltd.

ID: IN10THDH001 CATEGORY: Digital Health GEOGRAPHY: Thailand AUTHOR: Vidhi Upadhyay

Buy Now

Thailand 3D Imaging Market Executive Summary

Thailand's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The World Health Organization Global Health Expenditure database shows that Thailand's per capita health expenditure increased from $278.63 in 2018 to $296.17 in 2019. Thailand is often regarded as one of the most competitive countries in the world for high-quality, low-cost care. According to The Global Cancer Observatory 2020, out of a total population of 69.7 Mn, the number of new cases of cancer was 0.19 Mn with 0.12 Mn deaths. According to WHO statistics published in 2020, the number of Coronary Heart Disease fatalities in Thailand reached 51,305, accounting for 11.53% of all deaths.

Thailand's 3D Imaging market is quickly expanding, driven by rising demand for improved diagnostic and treatment technologies in the healthcare sector. A wide range of medical applications makes use of 3D Imaging. In July 2022, Lunit, a South Korean company, inked a contract with FujiFilm Thailand and Microsoft to deliver artificial intelligence (AI) cancer screening tools to Bangkok's Bumrungrad International Hospital under which Lunit INSIGHT CXR, a CE-marked chest x-ray analysis AI program, and Lunit INSIGHT MMG, an FDA-cleared AI solution for identifying breast cancer in its early stages, have been adopted.

Market Dynamics

Market Growth Drivers

Thailand's health expenditure has risen in recent years, with the government expanding its healthcare infrastructure and services. This is projected to fuel the expansion of the 3D Imaging market. The rising incidence of chronic illnesses and age-related ailments is driving demand for more advanced and precise medical imaging technologies, such as 3D imaging. Technological advancements are making 3D Imaging technology more accessible and inexpensive, fuelling demand for these technologies in the healthcare industry. Thailand has emerged as a medical tourism hotspot, with many people from various nations seeking treatment there. This has raised the demand for specialized diagnostic imaging technologies such as 3D imaging.

Market Restraints

Limited healthcare resources may limit investment in costly imaging technology, while a dearth of experienced staff, such as radiologists and imaging technicians, may impede their acceptance and use. High equipment costs may also be an obstacle to adoption, especially in smaller healthcare institutions and clinics. Regulatory barriers associated with the usage and import of medical equipment in Thailand may hinder the acceptance and expansion of the 3D Imaging market, while patient privacy issues may also arise when sensitive medical information is gathered and stored utilizing 3D Imaging technologies.

Competitive Landscape

Key Players

Siemens Healthineers
GE Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Healthcare
Toshiba Medical Systems
Tawada Healthcare
Meditop Co., Ltd (THA)

Notable Deals

In October 2022, Philips revealed two significant advancements in MR-only procedures for head and neck cancer radiation imaging and simulation
September 2022, Srisawan Hospital in Thailand signed a Memorandum of Understanding (MoU) with GE Healthcare to use digital technologies to enhance patient care outcomes and boost staff efficiency while lowering intensive care unit (ICU)-related healthcare expenditures
In September 2022, GE Healthcare’s deep-learning 3D imaging system received FDA-expanded approval. Also, it’s “AIR Recon DL” Received FDA Approval for 3D and Motion-Insensitive Imaging Applications for Superior Image Quality and Patient Experience in MRI

Healthcare Policies and Regulatory Landscape

Thailand's regulatory body for medical devices and imaging equipment is the Thai Food and Drug Administration (TFDA), which is in charge of medical device registration, import, and sale in the nation. The TFDA has created rules for medical device registration, including 3D Imaging technologies, and ensures that these devices meet safety, quality, and performance criteria. In addition to the TFDA, the Ministry of Public Health (MOPH) plays an important role in developing Thailand's healthcare policies and regulations, including the use of imaging technology.

Reimbursement Scenario

Thailand's national healthcare program, known as the Universal Coverage Scheme (UCS), largely provides funding for 3D Imaging. All Thai people are entitled to free or low-cost medical treatment under the UCS, which includes the utilization of imaging technology like 3D Imaging. However, medical treatment and imaging test reimbursement rates in Thailand might vary based on the type of facility, service, and region.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Thailand 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.